Emerging biosimilars market presents opportunities and challengesDecember 6, 2018Patient & Survivor Care
Comparing risk models guiding growth factor use in chemotherapyDecember 6, 2018Patient & Survivor Care
Mortality outcomes in hospitalized oncology patients after rapid response team activationDecember 6, 2018Patient & Survivor Care
Effectiveness of duloxetine in treatment of painful chemotherapy-induced peripheral neuropathy: a systematic reviewDecember 6, 2018Patient & Survivor Care
Symptom burdens related to chemotherapy-induced anemia in stage IV cancerDecember 5, 2018Patient & Survivor CareBreast CancerLung CancerLymphoma & Plasma Cell Disorders
Patterns of malignancies in patients with HIV-AIDS: a single institution observational studyNovember 27, 2018Patient & Survivor CareSarcoma & GISTGynecologic CancerLymphoma & Plasma Cell Disorders
Malignant olecranon bursitis in the setting of multiple myeloma relapseNovember 26, 2018Lymphoma & Plasma Cell DisordersPatient & Survivor Care
Collaboration is key to bridging the AYA cancer care divideOctober 31, 2018Patient & Survivor CarePediatrics
Prolonged survival in adenocarcinoma of unknown primary treated with chemoradiotherapyOctober 30, 2018Patient & Survivor Care
Marriage predicts for survival in patients with stage III non–small-cell lung cancerOctober 28, 2018Patient & Survivor Care
Finding that sweet spot where science, practice, and best-possible outcomes come togetherOctober 28, 2018Patient & Survivor Care
Advances in precision medicine help refine – and redefine – cancer careSeptember 28, 2018Patient & Survivor Care
